
We’re happy to share that Madison Medical Affiliates is once again in-network with all UnitedHealthcare insurance plans, effective October 1, 2025.
Ascension Wisconsin and UnitedHealthcare have finalized a new agreement that ensures continued access to in-network care for all UHC Commercial, Medicare, and Medicaid members. Any services received between October 1–13 will also be processed at in-network rates.
We are deeply grateful for your patience and understanding during this transition — and most of all, for the trust you place in us. It’s a privilege to care for you and your family, and we’re thrilled to welcome our UnitedHealthcare patients back with open arms.
As we work through this transition, please be patient with our team — we expect higher-than-usual call volumes over the next few days and will do our best to respond as quickly as possible.
Treatment with the UroLift® System uses a minimally invasive approach that provides rapid relief and recovery of BPH symptoms.1 It is an earlier treatment option that can get men off BPH medications and avoid major surgery. The goal of the UroLift System treatment is to relieve symptoms so you can get back to your life and resume your daily activities.
The UroLift® System treatment has demonstrated a significant improvement in quality of life for patients that is greater than reported for medications.2,3 The UroLift® System is the only BPH procedure shown not to cause new and lasting erectile or ejaculatory dysfunction*, while being a safe and effective treatment of lower urinary tract symptoms due to BPH.1,3-6
The UroLift® System uses a revolutionary approach to treating BPH that lifts and holds the enlarged prostate tissue so it no longer blocks the urethra. It is the only available BPH treatment performed by a urologist that does not require heating, cutting, or removal of the prostate tissue. The procedure is typically performed using local anesthesia in a physician's office or ambulatory surgery center. Patients typicall return home the same day without a catheter.1
1. Roehrborn, J Urol 2013, L.I.F.T. Study
2. AUA Guidelines 2003
3. Roehrborn et al. Can J Urol 2017
4. Roehrborn, Can J Urol 2015, 3-Year L.I.F.T. Study
5. Roehrborn, Urology Practice 2015, 2-Year L.I.F.T. Study
6. Roehrborn Urology Clinics 2016
*No instances of new, sustained erectile or ejaculatory dysfunction